Case Control Study
Copyright ©The Author(s) 2025.
World J Clin Oncol. May 24, 2025; 16(5): 107551
Published online May 24, 2025. doi: 10.5306/wjco.v16.i5.107551
Figure 1
Figure 1 Comparison of serum pro-inflammatory cytokines between control group and gastric carcinoma group. A: Comparison of interleukin (IL)-1β; B: Comparison of IL-2; C: Comparison of IL-6; D: Comparison of IL-8; E: Comparison of IL-12; F: Comparison of tumor necrosis factor-alpha; G: Comparison of interferon-γ. The data are presented as the mean ± SD. aP < 0.01 vs the control group, NS: No significance. GC: Gastric carcinoma.